Page 5 - Exact Sciences News Today

Impax Asset Management Group plc trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,945 shares of the medical research company’s stock after selling 413 shares during […]

Several new multitarget stool-based screening tests on the horizon may improve early colorectal cancer detection, according to findings from recent analyses.

Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that on April 10, 2024 it entered into privately negotiated exchange and purchase agreements with...

A weed you can find in almost any Oklahoma yard might be the key to curing cancer.Research on dandelions at the University of Central Oklahoma started in 2019,

Thematic ETFs are an easy way to play a trend rather than trying to pick a winner.

In this article, we discuss 11 best biotech ETFs to buy. If you want to skip our discussion on the biotech industry, head over to 5 Best Biotech ETFs To Buy. The new era in biotech is defined by the convergence of biology, data, and artificial intelligence. According to The Journal of mHealth, the focus […]

The new era in biotech is defined by the convergence of biology, data, and artificial intelligence.

This Medical News story discusses questions about multiple cancer early detection tests, 2 of which are already on the US market.

First analysis from ASCEND-2 confirms high detection rates and specificity achieved with multi-biomarker approach in most aggressive cancers and those with no standard-of-care screening test1 ...

Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its first quarter 2024 financial results after the close of the...